Artgen Biotech PJSC (MOEX:ISKJ)

Artgen Biotech PJSC Balance Sheet

Financials in millions RUB. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	503.35	544.94	201.66	193.29	107.39
Trading Asset Securities	-	27.39	25.4	0.51	0.51
Cash & Short-Term Investments	503.35	572.33	227.06	193.8	107.9
Cash Growth	-12.05%	152.07%	17.16%	79.61%	-39.49%
Accounts Receivable	67.3	81.83	67.86	83.2	90.18
Other Receivables	54.72	72.58	61.69	23.92	41.98
Receivables	122.01	205.38	185.11	131.76	151.46
Inventory	246.84	226.31	223.87	245.79	233.54
Other Current Assets	200.64	113.22	53.74	86.71	83.04
Total Current Assets	1,073	1,117	689.77	658.06	575.93
Property, Plant & Equipment	376.86	315.87	280.51	285	330.25
Long-Term Investments	96.91	161.33	193.34	120.62	54.35
Other Intangible Assets	858.12	174.9	150.1	128.6	116.93
Long-Term Deferred Tax Assets	115.23	90.83	83.03	86.12	76.03
Long-Term Deferred Charges	-	631.35	586.62	414.09	342.11
Other Long-Term Assets	151.47	-	-	-	-
Total Assets	2,671	2,544	2,045	1,737	1,512
Accounts Payable	102.91	53.41	33.87	35.94	35.38
Accrued Expenses	15	-	-	-	-
Short-Term Debt	-	0.73	0.73	0.2	0.19
Current Portion of Long-Term Debt	87.71	219.72	106.44	-	177.77
Current Portion of Leases	25.17	19.53	11.69	8.89	9.91
Current Income Taxes Payable	-	24.84	24.57	14.61	10.7
Other Current Liabilities	238.12	243.16	218.28	312.52	322.18
Total Current Liabilities	468.91	561.4	395.57	372.15	556.13
Long-Term Debt	480.5	427.2	601.38	494.23	175
Long-Term Leases	144.28	119.77	111.36	113.82	125.59
Other Long-Term Liabilities	504.13	460.96	366	296.49	240.38
Total Liabilities	1,598	1,569	1,474	1,277	1,097
Common Stock	9.27	9.27	9.27	8.5	7.5
Additional Paid-In Capital	626.58	625.13	612.1	567.43	151.93
Retained Earnings	365.43	318.15	146.45	94.13	69.42
Treasury Stock	-499.39	-421.99	-447.85	-446.98	-34.97
Comprehensive Income & Other	-94.51	-30.06	21.07	11.7	0.38
Total Common Equity	407.37	500.49	341.04	234.78	194.26
Minority Interest	666.25	474.25	229.22	225.78	220.74
Shareholders' Equity	1,074	974.73	570.26	460.56	415
Total Liabilities & Equity	2,671	2,544	2,045	1,737	1,512
Total Debt	737.65	786.96	831.6	617.13	488.46
Net Cash (Debt)	-234.31	-214.62	-604.55	-423.33	-380.56
Net Cash Per Share	-2.53	-2.32	-6.96	-5.29	-5.07
Filing Date Shares Outstanding	-	75.15	81.61	85	75
Total Common Shares Outstanding	-	75.15	81.61	85	75
Working Capital	603.94	555.84	294.2	285.9	19.81
Book Value Per Share	-	6.66	4.18	2.76	2.59
Tangible Book Value	-450.75	325.59	190.94	106.18	77.33
Tangible Book Value Per Share	-	4.33	2.34	1.25	1.03
Buildings	-	67.06	49.65	97.89	94.08
Machinery	-	375.42	353.72	336.45	325.07
Construction In Progress	-	-	-	0.05	0.9

Updated Sep 5, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.